Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Micro-costing for national-scale azithromycin mass drug administration to improve child survival in Niger.

PLOS global public health·2026

Same author

Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction: Follow-Up of a Randomized Clinical Trial.

JAMA ophthalmology·2026

Same author

The Effects of a Digital Mindfulness Intervention on Mental Health and Vision-Related Quality of Life in Non-infectious Uveitis.

Ophthalmology·2026

Same author

Predictors of home- vs. facility-based delivery among women living in rural Niger: a cross-sectional survey within the AVENIR cluster-randomised trial.

Journal of global health·2026

Same author

Comparing the Generalizability of Multiregional versus Locally Trained Deep Learning Models for Trachoma Detection.

Ophthalmology science·2026

Same author

Haemoglobin concentration thresholds that discriminate functional outcomes among children aged 6-30 months in eight countries: a pooled analysis of individual participant data.

BMJ global health·2026

Search research articles

Related Experiment Video

Updated: May 8, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.

Kieran S O'Brien¹, Ahmed M Arzika¹, Abdou Amza¹

¹From the Francis I. Proctor Foundation (K.S.O., E.L., B.P., Z.L., V.L., E.C., T.D., J.D.K., C.E.O., T.C.P., B.F.A., T.M.L.), the Departments of Ophthalmology (K.S.O., T.D., J.D.K., C.E.O., T.C.P., B.F.A., T.M.L.) and Epidemiology and Biostatistics (K.S.O., C.E.O., T.C.P., T.M.L.), and the Institute for Global Health Sciences (K.S.O., C.E.O., B.F.A., T.M.L.), University of California, San Francisco, San Francisco; and Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure (A.M.A., R.M., B.A., I.M.B., D.B., N.G., N.H., A.M.K., S.M., M.A.), and Programme Nationale de Santé Oculaire, Niamey (A.A., A.I.) - both in Niger.

The New England Journal of Medicine

|August 21, 2024

Summary

This summary is machine-generated.

Mass azithromycin distribution to children aged 1-59 months significantly reduced childhood mortality in sub-Saharan Africa. This approach proved more effective than limiting treatment to infants, highlighting a crucial public health strategy.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Related Experiment Videos

Last Updated: May 8, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Area of Science:

Global Health
Infectious Diseases
Pediatrics

Background:

Twice-yearly mass azithromycin distribution is a potential intervention for reducing childhood mortality in sub-Saharan Africa.
The World Health Organization recommended limiting distribution to infants (1-11 months) to mitigate antimicrobial resistance, a strategy not yet empirically tested.

Purpose of the Study:

To evaluate the effectiveness of mass azithromycin distribution to children aged 1-59 months compared to infants aged 1-11 months for reducing childhood mortality.
To assess the impact of different azithromycin distribution strategies on mortality rates in rural Niger.

Main Methods:

A randomized controlled trial involving 1273 communities in Niger over 2 years.
Communities were assigned to receive azithromycin for all children (1-59 months), only infants (1-11 months), or placebo.
Mortality was monitored by census workers unaware of group assignments.

Main Results:

Mass azithromycin distribution to children 1-59 months resulted in a 14% reduction in mortality compared to placebo (11.9 vs. 13.9 deaths per 1000 person-years; P<0.001).
Distribution to infants 1-11 months showed a non-significant 6% reduction in mortality compared to placebo (22.3 vs. 23.9 deaths per 1000 person-years).
Five serious adverse events were reported across all groups.

Conclusions:

Mass azithromycin distribution to children aged 1-59 months significantly reduces mortality and is more effective than targeting only infants.
Continued monitoring for antimicrobial resistance is essential.
The study provides evidence supporting broader azithromycin distribution for child survival in sub-Saharan Africa.